Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Public Health Burden of Nicotine Use Examined

J Clin Psychiatry; ePub 2016 Apr 26; Chou, Goldstein, et al

A recent study underscored the need to address nicotine use in clinical settings. Using data from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions-III, which included 36,309 subjects, researchers conducted weighted cross-tabulations and multivariate logistic regression analyses to estimate prevalence and examine psychiatric comorbidity of DSM-5 nicotine use disorder (NUD). They found:

• Prevalences of 12-month and lifetime DSM-5 NUD were 20.0% and 27.9%, respectively.

• NUD was more frequent among men, non-Hispanic whites, younger individuals, the previously married, those with less education and lower incomes, and those residing in rural areas.

• Adjusted for sociodemographic characteristics and additional psychiatric comorbidity, 12-month NUD and lifetime NUD were significantly associated with other substance abuse and antisocial personality disorders.

• 12-month severe NUD was generally associated with major depressive, bipolar I, bipolar II, panic, generalized anxiety, posttraumatic stress and schizotypal, borderline, and antisocial personality disorders.

• Individuals with current NUD and at least 1 psychiatric disorder comprised 11.1% of US adults but smoked 53.6% of total cigarettes consumed.

Citation: Chou SP, Goldstein RB, Smith SM, Huang B, Ruan WJ, et al. The epidemiology of DSM-5 nicotine use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. [Published online ahead of print April 26, 2016]. J Clin Psychiatry. doi:10.4088/JCP.15m10114.